Day: January 12, 2023

STOCKHOLM, SWEDEN, January 12, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has dosed the first patient in a clinical phase 1/2a study of the drug candidate ATRN-119, which is being evaluated as a treatment for advanced solid tumors by affecting a signaling pathway important for tumor DNA repair. The phase 1/2a clinical trial is a multi-center, open-label, dose-escalation and expansion study designed to test ATRN-119 monotherapy in patients with advanced solid tumors. The first part of the study will evaluate tolerability, pharmacokinetics, recommended phase 2 dose and analysis of patient biomarkers. The Phase 2a expansion part of the trial is designed to further evaluate the tolerability and efficacy of ATRN-119 as a monotherapy. Results from the study will be presented...

CASE_ IH_Patriot_50_Series_ SprayerNew_Holland_Straddle_Tractor_conceptNew_Holland_TK_Methane_Power_vineyard_crawler_tractorLondon, January 12, 2023 Case IH and New Holland, global agricultural brands of CNH Industrial, have been awarded 2022 Good Design Awards. The Case IH Patriot® 50 series sprayer and New Holland’s Straddle Tractor Concept and TK4 Tractor received recognition. Case IH’s Patriot 50 series sprayer is designed to help farmers work more productively and efficiently. From the comfort of the well-appointed cab, the operator has complete control of the vehicle’s advanced connectivity solutions and integrated spray technology. The latter produces reports on the vehicle’s spray rates which allows operators to accurately calculate input prices. New Holland’s Straddle Tractor Concept was realized in collaboration...

RENO, Nev., Jan. 12, 2023 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) – Ormat Technologies (NYSE: ORA) and PT Medco Power Indonesia (“Medco Power”) through their subsidiary company, PT Medco Cahaya Geothermal (“MCG”), signed a Financing Agreement with PT Sarana Multi Infrastruktur (Persero) (“SMI”) for development of Ijen Geothermal Power Plant. The signing was witnessed by Harris Yahya, Geothermal Director of the Ministry of Energy and Mineral Resources, Adi Lumakso Director of Generation Management of PT PLN (Persero), Hilmi Panigoro President Director of MedcoEnergi, Doron Blachar CEO of Ormat, Eka Satria President Director of Medco Power and Edwin Syahruzad President Director of SMI. The Ijen power plant will be developed in stages with the first phase of the development is expected to generate 34 MW in 2025....

Fourth Quarter Revenues and EPS Both Exceed Guidance; Gross Margin Moderately Lower than Guidance Range TAINAN, Taiwan, Jan. 12, 2023 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today pre-announced preliminary unaudited key financial results for the fourth quarter and full year 2022 ended December 31st, 2022. The fourth quarter revenues and EPS both exceeded the guidance issued on November 10th, 2022, while gross margin is moderately lower than the guidance range. Full year 2022 revenues achieved more than $1.2 billion. Preliminary, Unaudited Fourth Quarter 2022 Financial ResultsRevenues were $262.3 million, an increase of 22.8% from the third quarter of 2022, substantially outperforming the...

Building upon the company’s unique expertise in developing pharma grade probiotics, Infant Bacterial Therapeutics AB (IBT) has secured an exclusive global license from the Medical College of Wisconsin (MCW) to a technology platform consisting of genetically modified bacteria. IBT will investigate how to develop a pharma grade probiotic based on this platform that addresses the growing problem of hospital acquired infections, which are responsible for high morbidity and mortality rates. Antibiotic resistance is rising to dangerous levels across the world, including hospital acquired infections caused by vancomycin-resistant enterococci (VRE). VRE infections have become a serious public health challenge linked with the complexities of antibiotic resistance, resulting in 54,000 cases and 5,000 deaths among hospitalized patients in the...